Nox4-dependent ROS modulation by amino endoperoxides to induce apoptosis in cancer cells
1School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
Cell Death & Disease
|March 23, 2013
Summary
Novel amino endoperoxides selectively induce apoptosis in metastatic breast cancer cells. This new class of compounds, like 4-Me, targets cancer cells via redox mechanisms, offering a promising strategy against tumor metastasis.
Area of Science:
- Organic Chemistry
- Cancer Biology
- Pharmacology
Background:
- Tumor metastasis is a primary cause of cancer mortality.
- Anoikis resistance in cancer cells hinders current treatments.
- Endoperoxide compounds show anticancer potential but face challenges in clinical application.
Purpose of the Study:
- To develop stable, selectively cytotoxic amino endoperoxides.
- To investigate the anticancer mechanisms of novel endoperoxides.
- To evaluate the efficacy of these compounds against breast cancer metastasis.
Main Methods:
- One-pot synthesis of amino endoperoxides and derivatives.
- In vitro apoptosis assays on cancer and normal breast cells.
- Mechanistic studies involving Nox4 expression and reactive oxygen species (ROS) levels.
- In vivo studies using orthotopic breast tumor models.
Main Results:
- Successfully synthesized novel amino endoperoxides with good yield and stability.
- Identified 4 out of 14 compounds that selectively induce apoptosis in metastatic breast cancer cells.
- The potent compound 4-Me demonstrated selectivity for Nox4-high cancer cells.
- 4-Me reduced the O2(-):H2O2 ratio and increased ·OH levels, impairing tumor growth and metastasis in vivo.
Conclusions:
- Novel amino endoperoxides can be synthesized efficiently and exhibit selective anticancer activity.
- Redox-based apoptosis induction targeting Nox4 is a viable strategy for combating metastatic breast cancer.
- These findings support the clinical potential of endoperoxide-based anticancer therapies.
Related Concept Videos
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...